Trial of QLH12016 in Patients With Metastatic Castration Resistant Prostate Cancer

Clinical trial NCT05973149 · UNKNOWN

Trial details

NCT number: NCT05973149
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2023-08-31
Primary completion: 2025-08-31
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.